Jefferies upgraded Aperam (APEMY) to Buy from Hold with a EUR 47 price target The firm note the derating in the stock following Iran war escalation, adding that given the company’s cost leadership, a globally diversified footprint and a clear deleveraging path, Aperam offers attractive exposure to EU recovery and downside protection, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APEMY: